세계의 헬스케어 서드파티 물류 시장 보고서(2025년)
Healthcare Third-Party Logistics Global Market Report 2025
상품코드 : 1810908
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

헬스케어 서드파티 물류 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년 연평균 성장률(CAGR)은 9.2%로, 3,678억 8,000만 달러로 성장합니다. 예측 기간 중 예상되는 성장은 효율적인 공급망 관리에 대한 수요 증가, 온도 제어 물류에 대한 수요 증가, 바이오 제약 기업의 유통망 확대, 규제 준수에 대한 강조, 환자에 대한 직접 배송에 대한 수요 증가에 기인합니다. 이 기간 중 예상되는 주요 동향으로는 콜드체인 물류의 발전, 디지털 추적 시스템 통합, 기술 주도형 재고 관리, 실시간 모니터링 개선, 디지털 기술 혁신 등이 있습니다.

백신 수요의 확대는 향후 헬스케어 제3자 물류 시장의 성장을 촉진할 것으로 예측됩니다. 백신은 질병을 일으키지 않고 감염을 모방하여 면역 체계를 자극하여 특정 질병과 싸우도록 하는 생물제제입니다. 이러한 수요 증가는 전염병 발생률 증가와 광범위한 건강 위험으로부터 자신을 보호해야 할 필요성이 높아졌기 때문입니다. 헬스케어 제3자 물류는 공급망 전체에 걸쳐 안전하고 적시에 온도 관리된 운송 및 보관을 제공함으로써 백신에서 중요한 역할을 담당하고 있습니다. 예를 들어 2024년 7월, 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)는 여아 HPV 백신의 전 세계 최초 접종률이 2022년 20%에서 2023년 27%로 상승하여 2030년까지 90%에 도달하는 것을 목표로 하고 있다고 보고했습니다. 그 결과, 이러한 백신 수요 증가는 헬스케어 제3자 물류 시장의 성장을 가속하고 있습니다.

헬스케어 제3자 물류 시장의 주요 기업은 첨단 치료제의 안전하고 시간 제약이 있는 온도 관리된 배송을 보장하기 위해 세포 치료 및 유전자 치료용 특수 물류 플랫폼과 같은 혁신적인 솔루션을 개발하는 데 주력하고 있습니다. 이 플랫폼은 맞춤형 의료에 사용되는 깨지기 쉬운 생물학적 치료제의 섬세하고 시간 제약이 있고 온도 조절된 운송 및 보관을 관리하기 위해 설계된 정교한 시스템입니다. 예를 들어 미국에 본사를 둔 헬스케어 기업 맥케슨(McKesson Corporation)은 2024년 10월, 첨단 제3자 물류 및 전문 유통 서비스를 통해 세포 및 유전자 치료의 상용화를 지원하는 전문 부서인 Inspirogine을 출범시켰습니다. 이 혁신적인 플랫폼은 고급 공급망 관리, 온도 제어 보관, 실시간 추적을 결합하여 제품의 무결성을 유지하고 적시 배송을 보장하며 중요한 백신 및 치료제의 효율적인 유통을 촉진합니다. Inspirogene은 세포-유전자치료제 특유의 물류 니즈에 맞는 유연한 시스템을 제공하여 정확성과 신뢰성을 바탕으로 배송을 간소화하고 시장 진입을 지원합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Healthcare third-party logistics (3PL) involves the delegation of logistics and supply chain management tasks by healthcare organizations to specialized external service providers. These providers manage essential operations such as transportation, warehousing, inventory control, and regulatory compliance. In addition, they deliver value-added services like cold chain management, real-time tracking, serialization, and reverse logistics to ensure the secure, efficient, and compliant delivery of temperature-sensitive pharmaceuticals, biologics, and medical devices throughout the supply chain.

The primary categories of healthcare third-party logistics are cold chain logistics and non-cold chain logistics. Cold chain logistics pertains to the storage and transportation of temperature-sensitive items under controlled environments to preserve their integrity, safety, and effectiveness across the supply chain. This service employs multiple transportation modes, including ground, air, and sea freight. It also incorporates advanced technologies such as automated storage and retrieval systems, warehouse and transportation management systems, blockchain, IoT, AI and machine learning, and robotics. Temperature control options range from ambient and controlled to refrigerated, frozen, and cryogenic. These logistics solutions support a broad range of end users, including pharmaceutical and biopharmaceutical firms, hospitals and clinics, medical device manufacturers, research laboratories, healthcare providers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The healthcare third-party logistics market research report is one of a series of new reports from The Business Research Company that provides healthcare third-party logistics market statistics, including healthcare third-party logistics global market size, regional shares, competitors with healthcare third-party logistics market share, detailed healthcare third-party logistics market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare third-party logistics industry. The healthcare third-party logistics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The healthcare third-party logistics market size has grown strongly in recent years. It will grow from $236.32 billion in 2024 to $258.69 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth during the historic period can be attributed to the expanding outsourcing of logistics functions, the increasing use of automated storage systems, the rising prevalence of biologics and vaccines, the growing complexity of healthcare supply chains, and escalating healthcare expenses.

The healthcare third-party logistics market size is expected to see strong growth in the next few years. It will grow to $367.88 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth projected for the forecast period can be attributed to the rising demand for efficient supply chain management, an increasing need for temperature-controlled logistics, expanding distribution networks of biopharmaceutical companies, greater emphasis on regulatory compliance, and growing demand for direct-to-patient deliveries. Key trends expected during this period include advancements in cold chain logistics, the integration of digital tracking systems, technology-driven inventory management, improvements in real-time monitoring, and innovations in digital technologies.

The growing demand for vaccines is expected to drive the expansion of the healthcare third-party logistics market in the future. Vaccines are biological preparations that stimulate the immune system to recognize and combat specific diseases by mimicking infections without causing illness. This increasing demand arises from the rising incidence of infectious diseases, leading to a greater need for protection against widespread health risks. Healthcare third-party logistics plays a vital role in vaccines by providing safe, timely, and temperature-controlled transportation and storage throughout the supply chain. For example, in July 2024, the World Health Organization, an intergovernmental organization based in Switzerland, reported that global coverage of the first dose of the HPV vaccine among girls rose from 20% in 2022 to 27% in 2023, with a goal of reaching 90% by 2030. Consequently, this growing demand for vaccines is propelling the growth of the healthcare third-party logistics market.

Leading companies in the healthcare third-party logistics market are concentrating on creating innovative solutions, such as specialized logistics platforms for cell and gene therapies, to guarantee the safe, time-sensitive, and temperature-controlled delivery of advanced treatments. These platforms are sophisticated systems designed to manage the delicate, time-critical, and temperature-regulated transportation and storage of fragile biological therapies used in personalized medicine. For instance, in October 2024, McKesson Corporation, a healthcare company based in the US, launched Inspirogene, a specialized division dedicated to supporting the commercialization of cell and gene therapies through advanced third-party logistics and specialty distribution services. This innovative platform combines advanced supply chain management, temperature-controlled storage, and real-time tracking to maintain product integrity, ensure timely delivery, and facilitate efficient distribution of critical vaccines and therapies. Inspirogene provides a flexible system tailored to the unique logistical needs of cell and gene therapies, streamlining their delivery and aiding their market introduction with accuracy and reliability.

In April 2025, Morris & Dickson Inc., a US-based pharmaceutical wholesale distributor, acquired Presa Solutions for an undisclosed sum. Through this acquisition, Morris & Dickson Inc. seeks to offer an integrated supply chain solution to pharmaceutical and biotech partners by enhancing its third-party logistics (3PL) capabilities and providing an alternative to the traditional "Big 3" distributors. Presa Solutions Inc. is a US-based company specializing in healthcare third-party logistics (3PL) services.

Major players in the healthcare third-party logistics market are McKesson Corporation, Cencora Inc, Cardinal Health Inc, Federal Express Corporation, A.P. Moller - Maersk A/S, Kuhne + Nagel International AG, Schenker AG, CEVA Logistics India Private Limited, GEODIS SA, Rhenus SE And Co. KG, XPO Inc., Agility Logistics Private Limited, Allcargo Logistics Limited, Noatum Logistics India Private Limited, Barrett Distribution Centers Inc., UPS Supply Chain Solutions Inc., Buske Logistics Inc., Falcon International LLC, DHL Supply Chain India Private Limited, and Coldman Logistics Private Limited.

North America was the largest region in the healthcare third-party logistics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in healthcare third-party logistics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the healthcare third-party logistics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The healthcare third-party logistics market includes revenues earned by entities by providing services such as managing the storage, handling, and delivery of healthcare products, ensuring regulatory compliance, temperature control, secure distribution, and timely delivery to hospitals, clinics, pharmacies, and other healthcare institutions. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Healthcare Third-Party Logistics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on healthcare third-party logistics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for healthcare third-party logistics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The healthcare third-party logistics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Healthcare Third-Party Logistics Market Characteristics

3. Healthcare Third-Party Logistics Market Trends And Strategies

4. Healthcare Third-Party Logistics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Healthcare Third-Party Logistics Growth Analysis And Strategic Analysis Framework

6. Healthcare Third-Party Logistics Market Segmentation

7. Healthcare Third-Party Logistics Market Regional And Country Analysis

8. Asia-Pacific Healthcare Third-Party Logistics Market

9. China Healthcare Third-Party Logistics Market

10. India Healthcare Third-Party Logistics Market

11. Japan Healthcare Third-Party Logistics Market

12. Australia Healthcare Third-Party Logistics Market

13. Indonesia Healthcare Third-Party Logistics Market

14. South Korea Healthcare Third-Party Logistics Market

15. Western Europe Healthcare Third-Party Logistics Market

16. UK Healthcare Third-Party Logistics Market

17. Germany Healthcare Third-Party Logistics Market

18. France Healthcare Third-Party Logistics Market

19. Italy Healthcare Third-Party Logistics Market

20. Spain Healthcare Third-Party Logistics Market

21. Eastern Europe Healthcare Third-Party Logistics Market

22. Russia Healthcare Third-Party Logistics Market

23. North America Healthcare Third-Party Logistics Market

24. USA Healthcare Third-Party Logistics Market

25. Canada Healthcare Third-Party Logistics Market

26. South America Healthcare Third-Party Logistics Market

27. Brazil Healthcare Third-Party Logistics Market

28. Middle East Healthcare Third-Party Logistics Market

29. Africa Healthcare Third-Party Logistics Market

30. Healthcare Third-Party Logistics Market Competitive Landscape And Company Profiles

31. Healthcare Third-Party Logistics Market Other Major And Innovative Companies

32. Global Healthcare Third-Party Logistics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Healthcare Third-Party Logistics Market

34. Recent Developments In The Healthcare Third-Party Logistics Market

35. Healthcare Third-Party Logistics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기